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broad spectrum of HPV DNA, we did
not evaluate its persistence, or the
transcriptional activity or the viral load.
In addition, we cannot exclude that
specific HPV types may be involved in
a subgroup of HIV patients, as the
power of this study may have been
too low to reach statistical significance.
In conclusion, this is the first study
on HPV DNA prevalence in healthy
skin of HIV patients. The high preva-
lence of HPV infection in humans,
together with the lack of specific HPV
types and any relation with the immune
status of HIV patients, raises the ques-
tion of how HPV could affect the
development of skin cancer in these
patients (Feltkamp et al., 2008).
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TO THE EDITOR
Staphylococcus aureus infection is a
known trigger for skin inflammation
and can modulate immune responses.
Atopic dermatitis (AD), a chronic in-
flammatory pruritic skin disease, affects
10–20% of children and 1–3% of adults
(De Benedetto et al., 2009). Owing to
the loss of skin integrity by scratching,
as well as decreased levels of antimi-
crobial peptides in comparison with
normal skin or other inflammatory
diseases such as psoriasis (Ong et al.,
2002; Leung, 2003), patients with AD
are particularly susceptible to staphylo-
coccal skin infections, which can
further worsen their skin disease
(Bieber, 2008). Studies have suggested
several underlying mechanisms for sta-
phylococcus-mediated inflammation,
which include production of inflamma-
tory cytokines following either direct
infection of keratinocytes or immune
cells by the bacteria, or indirectly byAbbreviations: AD, atopic dermatitis; LTA, lipoteichoic acid; SPA, staphylococcal protein A
2502 Journal of Investigative Dermatology (2010), Volume 130
Y Yao et al.
SPA in Infected AD Lesions
bacterial products (Travers et al., 2001;
Leung, 2003; Sasaki et al., 2003; Baker,
2006). We have demonstrated pre-
viously that lipoteichoic acid (LTA), a
Gram-positive bacterial lipoprotein,
may have an important role in the
ability of S. aureus to exacerbate AD
lesions (Travers et al., 2010). In the
present study, we report that staphylo-
coccal protein A (SPA) could also
contribute to this process.
SPA is a 40–60 kDa bacteria surface
protein. It binds to the Fc region of IgG
via interaction with the heavy chain,
which disrupts opsonization and pha-
gocytosis, contributing to the virulence
of S. aureus (Foster, 2005). Studies have
shown that SPA can also activate the
tumor necrosis factor receptor-1, which
leads to NF-kB and activator protein 1
(AP-1) activation and subsequent pro-
duction of cytokines and chemokines,
promoting the inflammatory response
in staphylococcal pneumonia (Gomez
et al., 2004). Although SPA has
potent biological effects, a potential
pathologic role for this staphylococcal
protein or the amounts found within
infected skin lesions remain largely
unknown.
To assess the SPA levels in infected
AD lesions, we enrolled a total of 89
children (aged 3 months to 6 years)
with clinically impetiginized AD diag-
nosed using the criteria of Hanifen and
Rajka. Experiments in our protocol
were approved by the Indiana Univer-
sity Institutional Review Committee,
and adhered to the Helsinki Guidelines,
including using written, informed
patient consent in these human studies.
(Travers et al., 2010). Sixty-three pati-
ents returned for their second visit
following a 2-week regimen of oral
antibiotics (cephalexin or clindamycin
if allergic to cephalosporins or penicil-
lins) and topical corticosteroids. The
experimental procedures were pre-
viously described (Travers et al.,
2010). At each visit, subjects underwent
a clinical assessment of a clinically
infected lesion of dermatitis using the
eczema area and severity index score
(Hanifin et al., 2001). Lesional wash
fluid was collected, aliquoted and
stored at 80 1C until use. S. aureus,
S. epidermidis (coagulase-negative sta-
phylococcus) and group A streptococ-
cus colonies were quantified by
limiting dilution assay. Quantitative
measurement of SPA was performed
using ELISA (Assay Designs, Ann Arbor,
MI). Measurements of LTA and
cytokines IL-6, IL-8 and tumor necrosis
factor-a were done as previously
described (Travers et al., 2010). The
levels of SPA, LTA and cytokines in
wash fluid were first calculated based
on the area of the chamber (ng cm2),
and then converted to volume
(ng cm3) based on the estimation of
0.1 cm effective epidermal thickness.
S. aureus was detected from clini-
cally impetiginized AD lesions in
88.8% (79/89) of the subjects at their
first visit. Treatment with antibiotics
resulted in decreased amounts of
S. aureus on the lesional skin samples
and improvement of the lesional
eczema area and severity index scores
(Travers et al., 2010).
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Figure 1. Correlations between amounts of SPA and amounts of S. aureus, levels of TNF-a and LTA in lesional wash fluids, and clinical assessment of
inflammation in AD patients. Wash fluids were obtained from 89 first-visit (red circle) and 63 second-visit (blue triangle) subjects. (a) Amounts of SPA correlate
with S. aureus bacteria. Spearman correlation coefficient visit 1 r¼ 0.71; Po0.0001; visit 2 r¼ 0.45; P¼ 0.0002. (b) Amounts of SPA correlate with lesional EASI
scores. Spearman correlation coefficient visit 1 r¼0.36; P¼ 0.0005; visit 2 r¼0.15; P¼0.23. (c) Amounts of SPA correlate with levels of TNF-a. Spearman
correlation coefficient visit 1 r¼0.41; Po0.0001; visit 2 r¼0.04; P¼ 0.78. (d) Amounts of SPA correlate with levels of LTA. Spearman correlation coefficient
visit 1 r¼ 0.55; Po0.0001.
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Measurable amounts of SPA were
found in 91.0% (81/89) of the samples
during the first visit and in 55.6% (35/
63) during the second visit. Of note,
64.0% (57/89) of the first-visit samples
but only 9.5% (6/63) of the second-visit
samples had SPA levels 40.5 ng cm3.
As depicted in Figure 1a, there was a
strong positive correlation between
amounts of SPA and staphylococcal
bacterial colony-forming unit (visit 1:
r¼ 0.71, Po0.0001; visit 2: r¼0.45,
P¼0.0002). In addition, the level of
SPA was positively correlated with the
lesional eczema area and severity index
score at visit 1 (visit 1: r¼0.36,
P¼0.0005; visit 2: r¼ 0.15, P¼0.23)
(Figure 1b).
S. aureus infection or SPA itself has
been shown to induce the pro-inflam-
matory cytokine tumor necrosis
factor-a in primary human keratino-
cytes (Ezepchuk et al., 1996; Aufiero
et al., 2007). Our previous studies
indicated that biologically relevant le-
vels of pro-inflammatory cytokines can
be measured in many wash fluid speci-
mens derived from clinically impetigi-
nized AD lesions (Travers et al., 2010).
As shown in Figure 1c, the level of SPA
was positively correlated with the
amounts of tumor necrosis factor-a
for the first-visit samples (r¼0.41,
Po0.0001). Moreover, there was a
positive correlation between SPA
and other pro-inflammatory cytokines,
including IL-6 and IL-8 (data not
shown).
The dose of SPA needed to induce
cutaneous reactions in human skin has
been reported to be in the ngml1
range (White and Noble, 1985).
Therefore, pharmacologically active
(that is, 410 ng cm3) levels of SPA
are commonly encountered (in 30% of
the first-visit samples) in subjects
with impetiginized AD lesions. These
data suggested that SPA might
contribute to the worsening of AD
lesions by S. aureus infection. In fact,
it has been shown that topical
application of SPA after destroying
skin barrier function with a detergent
can induce AD-like skin inflammation
in mice (Terada et al., 2006). However,
it is also possible that the increased
skin inflammation might be simply
caused by other coexisting bacterial
products such as LTA and staphylococ-
cal toxins that have been implicated
in the worsening of AD in response
to infection (Ezepchuk et al., 1996;
Travers et al., 2001, 2010). Indeed,
we observed a strong positive
correlation between SPA and LTA
among first-visit samples (r¼0.55,
Po0.0001) (Figure 1d). It also remains
unclear at this point how SPA induces
skin inflammation, for example, the
cell type(s) and receptor(s) being in-
volved. Further investigations are war-
ranted to elucidate the role of SPA in
the pathogenesis of S. aureus-mediated
worsening of AD.
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